← Back to Analyst Consensus 
BZ Buy
Kanzhun Ltd
Current Price —
Implied Upside —
Analysts 27
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 27, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 18, 2026 | B of A Securities | initiate | — → Neutral | — | 53% |
| Jun 5, 2026 | Bernstein | upgrade | Market Perform → Outperform | — | 52% |
| Mar 20, 2026 | Barclays | maintain | Overweight → Overweight | $19 | 53% |
| Nov 19, 2025 | Barclays | maintain | Overweight → Overweight | $28 | 53% |
| Aug 22, 2025 | Barclays | maintain | Overweight → Overweight | $25 | 53% |
| Aug 21, 2025 | UBS | upgrade | Neutral → Buy | $26 | 54% |
| Aug 20, 2025 | Jefferies | maintain | Buy → Buy | $24 | 52% |
| Mar 13, 2025 | Barclays | maintain | Overweight → Overweight | $22 | 53% |
| Dec 9, 2024 | Barclays | maintain | Overweight → Overweight | $16 | 53% |
| Dec 9, 2024 | Bernstein | downgrade | Outperform → Market Perform | $15 | 52% |
| Nov 29, 2024 | Citigroup | maintain | Buy → Buy | $16 | 54% |
| Aug 30, 2024 | Barclays | maintain | Overweight → Overweight | $14 | 53% |
| May 22, 2024 | UBS | maintain | Neutral → Neutral | $23.5 | 54% |
| May 22, 2024 | JP Morgan | maintain | Overweight → Overweight | $24.5 | 54% |
| Mar 13, 2024 | Barclays | maintain | Overweight → Overweight | $27 | 53% |
| Mar 13, 2024 | New Street Research | upgrade | Neutral → Buy | $25 | 59% |
| Mar 12, 2024 | Macquarie | upgrade | Neutral → Outperform | $0 | 56% |
| Dec 20, 2023 | New Street Research | initiate | — → Neutral | $17 | 59% |
| Dec 13, 2023 | JP Morgan | initiate | — → Overweight | $20 | 54% |
| Sep 1, 2023 | UBS | downgrade | Buy → Neutral | $17 | 54% |
| Aug 31, 2023 | Barclays | maintain | Overweight → Overweight | $19 | 53% |
| Aug 30, 2023 | Bernstein | maintain | Outperform → Outperform | $20 | 52% |
| Aug 22, 2023 | Macquarie | downgrade | Outperform → Neutral | $16 | 56% |
| Aug 21, 2023 | Macquarie | downgrade | Outperform → Neutral | $0 | 56% |
| Jul 20, 2023 | Citigroup | initiate | — → Buy | $19 | 54% |
| May 3, 2023 | Macquarie | initiate | — → Outperform | $24.1 | 56% |
| Mar 29, 2023 | Barclays | maintain | — → Equal-Weight | $21 | 53% |
| Nov 14, 2022 | Goldman Sachs | upgrade | Neutral → Buy | $23 | 54% |
| Oct 28, 2022 | Barclays | maintain | — → Equal-Weight | $15 | 53% |
| Sep 13, 2022 | Barclays | initiate | — → Equal-Weight | $21 | 53% |
| Aug 16, 2022 | UBS | upgrade | Neutral → Buy | $27.5 | 54% |
| Dec 30, 2021 | Jefferies | initiate | — → Buy | $44 | 52% |
| Jul 26, 2021 | China Renaissance | initiate | — → Buy | $0 | 58% |
| Jul 23, 2021 | Goldman Sachs | initiate | — → Neutral | $41 | 54% |
Price Target Trend
Jun 8, 2026 Latest: $21.85 Oct 24, 2026
EPS Estimates
+1y $9.95
Lo: $8.74 Hi: $10.68
17 analysts ▲12
0q $2.26
Lo: $2.15 Hi: $2.40
8 analysts ▲4
+1q $2.23
Lo: $2.11 Hi: $2.34
7 analysts ▲4
0y $8.59
Lo: $8.31 Hi: $8.87
14 analysts ▲6
Cross-Platform Signals
No cross-platform signals in the last 90 days